在调节肥胖和相关代谢综合征方面,阿迪波涅丁的新进展
Yanqi Han1,2, Qianwen Sun1,2, Wei Chen1,2
1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
Journal of pharmaceutical analysis
|May 27, 2024
概括
阿迪波涅丁 (ADP) 提供了许多健康益处,改善新陈代谢和减少炎症. 准ADP途径为2型糖尿病和心血管疾病等代谢综合征提供了一个有前途的治疗策略.
科学领域:
- 代谢综合征研究 代谢综合征研究
- 内分泌学 在内分泌学.
- 阿迪波金信号传递
背景情况:
- 肥胖和代谢综合征是严重的健康风险.
- 阿迪波基因,特别是阿迪波涅丁 (ADP),在新陈代谢调节中起着至关重要的作用.
- ADP对葡萄糖/脂质代谢,胰岛素敏感性,炎症和氧化应激产生有益影响.
研究的目的:
- 提供关于阿迪波内克丁 (ADP) 的综合性审查.
- 探索ADP在各种代谢疾病中的作用.
- 突出针对ADP的治疗策略.
主要方法:
- 对阿迪波内克的生物功能进行文献综述.
- 对ADP参与代谢综合征的分析.
- 检查调节ADP的治疗方法.
主要成果:
- ADP 改善葡萄糖和脂质代谢,增强胰岛素敏感性.
- ADP可以减少氧化应激和炎症.
- ADP与2型糖尿病,心血管疾病,NAFLD,肉症,神经退行性疾病和癌症有关.
结论:
- 提高ADP水平或激活其受体是一种潜在的治疗策略.
- 了解ADP基因调节,多元化和分泌是开发治疗的关键.
- 本综述提供了ADP的全面概述,以更深入地理解和治疗开发.
相关概念视频
Obesity
456
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
456
Regulation of Food Intake
220
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
220
Overview of Lipid Metabolism
1.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.4K
Glucagon-like Receptor Agonists
318
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
318
Regulation of Metabolism
9.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.4K


